文献速递肥胖与代谢综合征

妊娠期肥胖女性补充二十二碳六烯酸对胎盘细胞信号传导和营养转运能力的影响

Docosahexaenoic Acid Supplementation in Pregnancy Modulates Placental Cellular Signaling and Nutrient Transport Capacity in Obese Women.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该研究在38名孕前体重指数≥30 kg/m²的孕妇中,从孕26周至足月每日补充DHA 800 mg(藻油)或安慰剂。DHA补充增加了红细胞和胎盘膜的DHA水平,降低了胎盘炎症、氨基酸转运蛋白表达和活性,并增加了脂肪酸转运蛋白4的胎盘蛋白表达,但未影响母体炎症状态、胰岛素敏感性或血脂。

要点

  • 肥胖孕妇每日补充DHA 800 mg可提高红细胞和胎盘膜DHA水平。
  • DHA补充降低胎盘炎症、氨基酸转运蛋白表达及活性(P < 0.01)。
  • DHA补充未改变母体炎症状态、胰岛素敏感性或血脂。

核心结论

  • 妊娠期补充DHA可降低胎盘炎症,并差异化调节胎盘营养转运能力,可能减轻母体肥胖对胎盘功能的不良影响。

研究设计与样本

  • 随机对照试验,38名孕前体重指数≥30 kg/m²的孕妇从孕26周至足月每日补充DHA 800 mg(藻油)或安慰剂(玉米/大豆油),在孕26周和36周采集母体空腹血,足月采集胎盘。

主要发现

  • DHA补充增加了红细胞DHA水平(P < 0.0001)和胎盘膜DHA水平(P < 0.0001)。
  • DHA补充未影响母体炎症状态、胰岛素敏感性或血脂。
  • DHA补充降低了胎盘炎症、氨基酸转运蛋白表达和活性(P < 0.01)。
  • DHA补充增加了胎盘脂肪酸转运蛋白4的蛋白表达(P < 0.05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Maternal obesity in pregnancy has profound impacts on maternal metabolism and promotes placental nutrient transport, which may contribute to fetal overgrowth in these pregnancies. The fatty acid docosahexaenoic acid (DHA) has bioactive properties that may improve outcomes in obese pregnant women by modulating placental function. OBJECTIVE: To determine the effects of DHA supplementation in obese pregnant women on maternal metabolism and placental function. DESIGN: Pregnant women were supplemented with DHA or placebo. Maternal fasting blood was collected at 26 and 36 weeks' gestation, and placentas were collected at term. SETTING: Academic health care institution. SUBJECTS: Thirty-eight pregnant women with pregravid body mass index ≥30 kg/m2. INTERVENTION: DHA (800 mg, algal oil) or placebo (corn/soy oil) daily from 26 weeks to term. MAIN OUTCOMES: DHA content of maternal erythrocyte and placental membranes, maternal fasting blood glucose, cytokines, metabolic hormones, and circulating lipids were determined. Insulin, mTOR, and inflammatory signaling were assessed in placental homogenates, and nutrient transport capacity was determined in isolated syncytiotrophoblast plasma membranes. RESULTS: DHA supplementation increased erythrocyte (P < 0.0001) and placental membrane DHA levels (P < 0.0001) but did not influence maternal inflammatory status, insulin sensitivity, or lipids. DHA supplementation decreased placental inflammation, amino acid transporter expression, and activity (P < 0.01) and increased placental protein expression of fatty acid transporting protein 4 (P < 0.05). CONCLUSIONS: Maternal DHA supplementation in pregnancy decreases placental inflammation and differentially modulates placental nutrient transport capacity and may mitigate adverse effects of maternal obesity on placental function.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lager S, Ramirez VI, Acosta O, et al. Docosahexaenoic Acid Supplementation in Pregnancy Modulates Placental Cellular Signaling and Nutrient Transport Capacity in Obese Women. J Clin Endocrinol Metab. 2017. PMID: 29053802. doi:10.1210/jc.2017-01384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。